Hoyle Lee Whiteside

Hoyle Lee Whiteside

Auto-generated profile, based on publicly available information

Hoyle Lee Whiteside

Division of Internal Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
HWHoyle L. Whiteside
Hoyle L. Whiteside
ANArun Nagabandi
Arun Nagabandi
DKDeepak Kapoor
Deepak Kapoor

1 December 2019 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
HWHoyle L. Whiteside
Hoyle L. Whiteside
ANArun Nagabandi
Arun Nagabandi
DKDeepak A Kapoor
Deepak A Kapoor

1 September 2018 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
HWHoyle L. Whiteside
Hoyle L. Whiteside
SRSupawat Ratanapo
Supawat Ratanapo
ANArun Nagabandi
Arun Nagabandi
DKDeepak Kapoor
Deepak Kapoor

1 April 2018 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
HWHoyle L. Whiteside
Hoyle L. Whiteside
SRSupawat Ratanapo
Supawat Ratanapo
ASAlbert Sey
Albert Sey
AOAbdullah Omar
Abdullah Omar
DKDeepak Kapoor
Deepak Kapoor

26 February 2019 in World Journal of Cardiology
Verified
Journal Article
Open access
HWHoyle L Whiteside
Hoyle L Whiteside
ANArun Nagabandi
Arun Nagabandi
KBKristen Brown
Kristen Brown
DADeepak N Ayyala
Deepak N Ayyala
GSGyanendra K Sharma
Gyanendra K Sharma
Prevalence and clinical characteristics associated with left atrial thrombus detection: Apixaban

19 July 2022 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
HWHoyle L. Whiteside
Hoyle L. Whiteside
DHDustin Hillerson
Dustin Hillerson
AAAhmed Abdel-Latif
Ahmed Abdel-Latif
VGVedant Gupta
Vedant Gupta
Background: The application of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in contemporary management of cardiogenic shock (CS) has dramatically increased. Despite increased utilization, few predictive models exist to estimate patient survival based on pre-ECMO characteristics. Furthermore, the prognostic implications of pre-ECMO cardiac arrest are not well defined. Methods: Utilizing an institutional VA-ECMO database, all consecutive patients undergoing VA-ECMO for the management of CS from January 1, 2014, to July 1, 2019, were identified. Survival to hospital discharge was analyzed based on cannulation indication in patients with and without pre-ECMO cardiac arrest. Patients who received extracorporeal cardiopulmonary resuscitation (eCPR) were analyzed separately. Results: Of the 214 patients identified, 110 did not suffer a cardiac arrest prior to cannulation (cohort 1), 57 patients had a cardiac arrest with sustained ROSC (cohort 2), and 47 were cannulated as a component of eCPR (cohort 3). Despite sustained ROSC (cohort 2), the presence of pre-ECMO cardiac arrest was associated with a significant reduction in survival to hospital discharge (22.8% vs. 55.5% in cohort 1; p < 0.001). Comparatively, survival to discharge was similar in patients undergoing eCPR (22.8% vs. 17.0%; p = 0.464). Finally, patients with a cardiac arrest were significantly more likely to have a neurological etiology death with VA-ECMO than patients supported prior to hemodynamic collapse (18.3% vs. 2.7%; p < 0.001). This result is seen in those with sustained ROSC (21.1% vs. 2.7%; p < 0.001) and those with eCPR (14.9% vs. 2.7%; p = 0.004). Conclusion: In our cohort, pre-ECMO cardiac arrest carries a negative prognostic value across all indications and is associated with an increased prevalence of neurological-etiology death. This finding is true in patients with sustained ROSC as well as those resuscitated with eCPR. Cardiac arrest can inform survival probability with VA-ECMO as early implementation of VA-ECMO may mitigate adverse outcomes in patients at the highest risk of hemodynamic collapse.